Chitosan derivative-based hemostat: Irritation, hypersensitivity and absorbability study
Keywords:
Clinical, Chitosan Derivative-based Hemostat, Irritation, Hypersensitivity, AbsorbabilityAbstract
The objective of this study was to evaluate the safety of a carboxymethylchitosan-based hemostatic prototype for internal use, in terms of irritation, hypersensitivity and absorbability. Skin irritation and delayed-type hypersensitivity tests of the prototype in humans (n=30) were assessed by a patch test method. The human skin sites were graded and photographed after patch removal at each time point using a 4-point (0-3+) grading scale of increasing irritation related to ISO 10993-10:2002(E) and a 6-point grading scale of increasing allergy related to International Contact Dermatitis Research Group (ICDRG). The results demonstrated that the chitosan derivative-based hemostat did not cause skin irritation and delayed-type hypersensitivity on the tested humans’ skin. The absorbability of the hemostatic prototype was evaluated in the surgical treatment of penile paraffinoma in ten patients, which was conducted at Angthong Hospital, using a scrotal flap method. This method normally involved two surgical stages. In the first stage, two prototype specimens (2.5 cm x 2.5 cm x 0.20 cm) were implanted inside a patient’s treated area until the second operation was performed, normally in three months. The clinical results revealed that, after the whole treatment, no remaining specimens were physically observed. Furthermore, the histological results of the tissues where the specimens had been implanted showed no sample residues, indicating that the chitosan derivative-based hemostat was completely absorbed within three months.Downloads
References
Muzzarelli, R.A.A. (1988). Carboxymethylated chitins and chitosans. Carbohydr Polym. 8 : 1-21.
Janvikul, W., Uppanan, P., Thavornyutikarn, B., Prateepasen, R. and Swasdison, S. (2007). Fibroblast interaction with carboxymethylbased hydrogel. J. Mater. Sci.: Mater. Med. 18(5) : 943-949.
Janvikul, W., Uppanan, P., Thavornyutikarn, B., Krewraing, J. and Prateepasen, R. (2006). In vitro comparative haemostatic studies of chitin, chitosan, and their derivatives. J. Appl. Polym. Sci. 102 : 445-451.
Jayakumar, R., Prabaharan, M., Nair, S.V., Tokura,S., Tamura, Selvamurugan,H. N. (2010). Novel carboxymethyl derivatives of chitin and chitosan materials and their biomedical applications. Prog. Mater. Sci. 55: 675-709.
Angspatt, A., Taweerattanasil, B., Janvikul, W., Chokrungvaranont, P. and Sirimaharaj, W. (2011). Carboxymethylchitosan, alginate and tulle gauze wound dressing : a comparative study in the treatment of partial-thicknees wounds. Asian Biome-dicine. 5(3) : 413-416.
Janvikul, W., Uppanan, P., Kosorn, W., Phulsuksombati, D. and Prateepasen, R. (2006). Evaluation of efficacy of chitosan derivative based hemostat : In Vitro and In Vivo studies. The 2nd International Symposium on Biomedical Engineering (ISBME2006):281-283.
Chang, J., Liu, W., Han, B. and Liu, B. (2008). The evaluation on biological properties of carboxymethyl-chitosan and carboxymethyl-chitin. J. Ocean Univ. China (English Edition) 7(4) : 404-410.
Zheng, M., Han, B., Yang, Y. and Liu, W. (2011). Synthesis, characterization and biological safety of O-carboxymethyl chitosan used to treat Sarcoma 180 tumor. Carbohydr. Polym. 86 : 231-238.
International Organization for Standardization. (2002). Biological evaluation of medical devices - Part
: Tests for irritation and delayed-type hypersen-sitivity. International Standard. ISO 10993-10 : 10-49.
York, M., Grilfiths, H.A., Whittle, E. and Basketter, D.A. (1996). Evaluation of a human patch test for the identification and classification of skin irritation potential. Contact Dermatitis. 4 : 202-212.
Ricchiuti, V.S., Richman, M.B., Haas, C.A., Desai, D. and Cai, D.X. (2002). Sclerosing lipogranuloma of the testis. Urology. 60(3) : 515.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2013 Journal of Metals, Materials and Minerals
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Authors who publish in this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.